Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 22, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - May 22, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/15/17 - "Crystal Forms of Azetidinone Compounds and Preparing Methods Thereof" in Patent Application Approval Process (USPTO 20170114016)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Wei, Hongyuan; Liu, Chongjun; Zhao, Xuyang; Xu, Xiaojie; Bai, Hua; Zhang, Yuncai, filed on December 21, 2016, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This pat
5/15/17 - "Hydantoin Derivative-Containing Pharmaceutical Composition" in Patent Application Approval Process (USPTO 20170112812)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors NODA, Hiroshi; KITAMURA, Hidetomo; TAMURA, Tatsuya, filed on June 9, 2014, was made available online on May 4, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Chug
5/15/17 - "Recombinant Human Epo-Fc Fusion Proteins with Prolonged Half-Life and Enhanced Erythropoietic Activity in Vivo" in Patent Application Approval...
"Recombinant Human Epo-Fc Fusion Proteins with Prolonged Half-Life and Enhanced Erythropoietic Activity in Vivo" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Wang, Haitao; Du, Yong; Zhang, Rui; Xu, Jing; Liu, Longbin, filed on June 27, 2016, was made ava
5/15/17 - 13th Annual EMD Serono Specialty Digest Details Utilization and Clinical Management Trends
By a News Reporter-Staff News Editor at Managed Care Weekly Digest EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced the launch of the 13th edition of the EMD Serono Specialty Digest? at the Asembia Specialty Pharmacy Summit in Las Vegas, NV. The Digest is an annual industry resource
5/15/17 - A transplant and a cure: Penn team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors
By a News Reporter-Staff News Editor at Pharma Business Week CHICAGO Ten patients at Penn Medicine have been cured of the Hepatitis C virus following lifesaving kidney transplants from deceased donors who were infected with the disease. Early data from the study were presented today by David S. Goldberg, MD, MSCE, an assistant professor of Medi
5/15/17 - Abbott Laboratories Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Apr. 28, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on April 28, 2017. The SEC file number is 0001179110-17-006291.. A U.S. Securities and Exchange Commission filing is a
5/15/17 - Abbott Laboratories Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (May. 2, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on May 2, 2017. The SEC file number is 0001179110-17-006403.. A U.S. Securities and Exchange Commission filing is a fo
5/15/17 - Abbott Laboratories Files SEC Form 8-K, Current Report (Apr. 28, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on April 28, 2017. The SEC file number is 0001104659-17-027924.. A U.S. Securities and Exchange Commission filing is a
5/15/17 - Abbott Laboratories Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans (Apr. 28, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on April 28, 2017. The SEC file number is 0001104659-17-027888.. A U.S. Securities and Exchange Commission filing is a
5/15/17 - AbbVie Demonstrates Leadership in Gastroenterology and Hepatology with New Data and Late-Breaking Studies to be Presented at Digestive Disease Week
By a News Reporter-Staff News Editor at Clinical Trials Week- AbbVie, a global biopharmaceutical company, announced that data from 20 abstracts in gastroenterology and hepatology programs will be presented at Digestive Disease Week 2017, May 6- 9, in Chicago. "AbbVie's research presented at DDW this year represents our commitment to developin
5/15/17 - Acadia Pharmaceuticals Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements (Apr. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on April 27, 2017. The SEC file number is 0001193125-17-143384.. A U.S. Securities and Exchange Commission fil
5/15/17 - Acadia Pharmaceuticals Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material (Apr. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on April 27, 2017. The SEC file number is 0001193125-17-143397.. A U.S. Securities and Exchange Commission fil
5/15/17 - Acceleron Pharma Inc. Files SEC Form 8-K, Current Report (Apr. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on April 27, 2017. The SEC file number is 0001280600-17-000019.. A U.S. Securities and Exchange Commission filing is
5/15/17 - Acceleron Pharma Inc. Files SEC Form 8-K, Current Report (May. 2, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on May 2, 2017. The SEC file number is 0001280600-17-000023.. A U.S. Securities and Exchange Commission filing is a
5/15/17 - Acelrx Pharmaceuticals Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements (Apr. 28, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acelrx Pharmaceuticals Inc. was posted on April 28, 2017. The SEC file number is 0001437749-17-007491.. A U.S. Securities and Exchange Commission fil
5/15/17 - Acelrx Pharmaceuticals Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material (Apr. 28, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acelrx Pharmaceuticals Inc. was posted on April 28, 2017. The SEC file number is 0001437749-17-007492.. A U.S. Securities and Exchange Commission fil
5/15/17 - Acorda to Present at the Deutsche Bank 42nd Annual Healthcare Conference
By a News Reporter-Staff News Editor at Pharma Business Week Acorda Therapeutics, Inc. will present at the Deutsche Bank 42nd Annual Healthcare Conference in Boston on Thursday, May 4, 2017 at 11:20 a.m. EDT. About Acorda Therapeutics Founded in 1995, Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore.
5/15/17 - Adamas Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Apr. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Adamas Pharmaceuticals Inc. was posted on April 27, 2017. The SEC file number is 0001628280-17-004439.. A U.S. Securities and Exchange Commission fil
5/15/17 - Aerie Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (May. 2, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on May 2, 2017. The SEC file number is 0001193125-17-154085.. A U.S. Securities and Exchange Commission filing
5/15/17 - Aerie Pharmaceuticals Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements (Apr. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on April 27, 2017. The SEC file number is 0001628280-17-004423.. A U.S. Securities and Exchange Commission fili
5/15/17 - Aerie Pharmaceuticals Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material (Apr. 27, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on April 27, 2017. The SEC file number is 0001193125-17-142998.. A U.S. Securities and Exchange Commission fili
5/15/17 - Aeterna Zentaris Announces that ZoptEC Phase 3 Clinical Study of Zoptrex? Did Not Achieve its Primary Endpoint
By a News Reporter-Staff News Editor at Clinical Trials Week Aeterna Zentaris Inc. announced that the ZoptEC Phase 3 clinical study of Zoptrex? in women with locally advanced, recurrent or metastatic endometrial cancer did not achieve its primary endpoint of demonstrating a statistically significant increase in the median period of overall surv
5/15/17 - Aeterna Zentaris Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)] (Apr. 28, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeterna Zentaris Inc. was posted on April 27, 2017. The SEC file number is 0001047469-17-003010.. A U.S. Securities and Exchange Commission filing is
5/15/17 - Aeterna Zentaris Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Apr. 28, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeterna Zentaris Inc. was posted on April 27, 2017. The SEC file number is 0001104659-17-027109.. A U.S. Securities and Exchange Commission filing is
5/15/17 - Aeterna Zentaris Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (May. 1, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeterna Zentaris Inc. was posted on May 1, 2017. The SEC file number is 0001104659-17-028299.. A U.S. Securities and Exchange Commission filing is a
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415